Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
15843 Guild Court, Jupiter, FL, 33478, US
Vetio is a Contract Development and Manufacturing Organization (CDMO) for Animal Health / veterinary drugs. Vetio offers turn-key CMC services, including: Product Development, Technical Services, Analytical Services, and Contract Manufacturing of numerous dosage forms. Vetio operates out of 4 facilities around the world in the U.S., Canada, UK and Ireland.
Hahn joins Nucleus RadioPharma after serving as CEO-partner of Flagship Pioneering and CEO of Harbinger Health since 2021.
By: Charlie Sternberg
In partnership with the University of Oxford’s Pandemic Sciences Institute, the grant will advance oral vaccine delivery.
By: Rachel Klemovitch
Financing supports the execution of early-stage clinical trials for Anocca’s lead program, VIDAR-1.
Meeting Global Injectable Demand
Released By Rovi Pharma Industrial Services
Platform and product releases span OPUS, MINT, POET, and SPI.
Will expand domestic active pharmaceutical ingredient (API) production in the U.S.
New alliance is dedicated to advancing lipid nanoparticle (LNP) technology and accelerating the development of next-generation therapeutics.
The site is also expanding its High Potency Active Pharmaceutical Ingredient and Antibody Drug Conjugate capacity.
Avista will leverage Forge’s FUEL platform to manufacture AAV for AVST-101, Avista’s lead gene therapy to treat patients with X-linked retinoschisis (XLRS).
Certifies ElevateBio’s compliant and scalable manufacturing capabilities for advanced therapies using U.S. and E.U. commercial-level evaluation standards.
The new facility designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field.
Sartorius supports commercialization and joint development of solutions based on Nanotein’s NanoSpark platform.
Strategic expansion is designed to advance gene therapy development and manufacturing.
CEO Dr. Johannis Willem van Vliet will leave the company shortly as the company transitions to a CDMO.
Becomes one of the largest global suppliers of Pegfilgrastim biosimilar.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
